Atlas Trials

Pharmacokinetic Study of Intranasal RX0041-002 in Hepatic-Impaired Individuals and Subjects With Normal Hepatic Function

Clinical trial NCT02775981 · COMPLETED

Trial details

NCT number
NCT02775981
Sponsor
Pharmaceutical Project Solutions, Inc.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Analgesic Allergy
Start date
2016-02-01
Primary completion
2016-07-01
Enrollment
24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.